- 現金殖利率: 0.43%、總殖利率: 5.17%、5年平均現金配發率: 43.6%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 0.98 | -41.32 | 0.20 | -75.0 | 0.50 | 150.0 | 20.41 | -57.4 | 51.02 | 326.02 | 71.43 | 19.29 |
| 2024 (4) | 1.67 | -47.81 | 0.80 | -46.67 | 0.20 | -60.0 | 47.90 | 2.2 | 11.98 | -23.35 | 59.88 | -4.19 |
| 2023 (3) | 3.20 | 6.67 | 1.50 | 0.0 | 0.50 | 66.67 | 46.88 | -6.25 | 15.62 | 56.25 | 62.50 | 4.17 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 0.11 | -45.0 | -70.27 | 0.31 | -13.89 | -46.55 | 0.11 | -88.78 | -70.27 |
| 25Q4 (7) | 0.20 | 225.0 | -47.37 | 0.36 | 0 | -32.08 | 0.98 | 25.64 | -41.32 |
| 25Q3 (6) | -0.16 | -127.12 | -141.03 | 0.00 | 100.0 | -100.0 | 0.78 | -18.75 | -39.53 |
| 25Q2 (5) | 0.59 | 59.46 | 168.18 | -0.08 | -113.79 | -125.81 | 0.96 | 159.46 | 1.05 |
| 25Q1 (4) | 0.37 | -2.63 | 0.0 | 0.58 | 9.43 | 0.0 | 0.37 | -77.84 | 0.0 |
| 24Q4 (3) | 0.38 | -2.56 | 0.0 | 0.53 | 211.76 | 0.0 | 1.67 | 29.46 | 0.0 |
| 24Q3 (2) | 0.39 | 77.27 | 0.0 | 0.17 | -45.16 | 0.0 | 1.29 | 35.79 | 0.0 |
| 24Q2 (1) | 0.22 | 0.0 | 0.0 | 0.31 | 0.0 | 0.0 | 0.95 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 1.37 | 37.0 | 12.68 | 5.67 | -5.5 | 4.09 | N/A | - | ||
| 2026/3 | 1.0 | -42.05 | -7.16 | 4.3 | -10.11 | 4.3 | 1.23 | - | ||
| 2026/2 | 1.72 | 8.93 | 36.9 | 3.3 | -10.97 | 4.73 | 1.12 | - | ||
| 2026/1 | 1.58 | 11.21 | -35.53 | 1.58 | -35.53 | 4.77 | 1.11 | - | ||
| 2025/12 | 1.42 | -19.46 | -7.3 | 16.82 | -7.04 | 4.85 | 1.08 | - | ||
| 2025/11 | 1.77 | 6.3 | -1.88 | 15.4 | -7.02 | 4.37 | 1.2 | - | ||
| 2025/10 | 1.66 | 75.59 | 16.91 | 13.63 | -7.64 | 3.92 | 1.34 | - | ||
| 2025/9 | 0.95 | -27.7 | -21.43 | 11.97 | -10.26 | 3.58 | 1.67 | - | ||
| 2025/8 | 1.31 | -1.49 | -10.29 | 11.02 | -9.15 | 3.8 | 1.58 | - | ||
| 2025/7 | 1.33 | 14.54 | -12.81 | 9.71 | -8.99 | 3.71 | 1.62 | - | ||
| 2025/6 | 1.16 | -5.34 | -11.94 | 8.39 | -8.36 | 3.6 | 1.46 | - | ||
| 2025/5 | 1.23 | 0.93 | -10.23 | 7.23 | -7.76 | 3.51 | 1.49 | - | ||
| 2025/4 | 1.21 | 12.87 | -18.82 | 6.0 | -7.24 | 3.55 | 1.48 | - | ||
| 2025/3 | 1.08 | -14.54 | -22.33 | 4.79 | -3.75 | 4.79 | 1.18 | - | ||
| 2025/2 | 1.26 | -48.7 | -30.75 | 3.71 | 3.41 | 5.25 | 1.08 | - | ||
| 2025/1 | 2.45 | 59.91 | 38.44 | 2.45 | 38.44 | 5.79 | 0.98 | - | ||
| 2024/12 | 1.53 | -14.75 | -24.85 | 18.09 | -15.26 | 4.75 | 1.13 | - | ||
| 2024/11 | 1.8 | 26.67 | -0.61 | 16.56 | -14.25 | 4.42 | 1.22 | - | ||
| 2024/10 | 1.42 | 17.99 | -18.56 | 14.76 | -15.66 | 4.08 | 1.32 | - | ||
| 2024/9 | 1.2 | -17.44 | -4.65 | 13.34 | -15.34 | 4.19 | 1.34 | - | ||
| 2024/8 | 1.46 | -4.26 | -36.33 | 12.13 | -16.27 | 4.3 | 1.31 | - | ||
| 2024/7 | 1.52 | 15.68 | -5.31 | 10.67 | -12.51 | 4.21 | 1.34 | - | ||
| 2024/6 | 1.32 | -3.5 | -17.12 | 9.15 | -13.6 | 4.18 | 1.06 | - | ||
| 2024/5 | 1.36 | -8.72 | -6.37 | 7.83 | -12.98 | 4.24 | 1.04 | - | ||
| 2024/4 | 1.5 | 7.99 | -14.94 | 6.47 | -14.25 | 4.7 | 0.94 | - | ||
| 2024/3 | 1.38 | -23.8 | -12.62 | 4.97 | -14.05 | 4.97 | N/A | - | ||
| 2024/2 | 1.82 | 2.54 | 24.44 | 3.59 | -14.59 | 5.63 | N/A | - | ||
| 2024/1 | 1.77 | -13.19 | -35.37 | 1.77 | -35.37 | 5.62 | N/A | - | ||
| 2023/12 | 2.04 | 12.74 | -32.37 | 21.35 | 10.12 | 5.6 | N/A | - | ||
| 2023/11 | 1.81 | 3.79 | -0.72 | 19.31 | 17.96 | 4.82 | N/A | - | ||
| 2023/10 | 1.74 | 38.15 | 3.64 | 17.5 | 20.3 | 5.3 | N/A | - | ||
| 2023/9 | 1.26 | -44.88 | -13.7 | 15.76 | 22.48 | 5.16 | N/A | - | ||
| 2023/8 | 2.29 | 42.37 | 20.85 | 14.49 | 27.12 | 5.49 | N/A | - | ||
| 2023/7 | 1.61 | 1.25 | -4.83 | 12.2 | 28.38 | 4.66 | N/A | - | ||
| 2023/6 | 1.59 | 9.02 | 36.47 | 10.59 | 35.56 | 4.81 | N/A | - | ||
| 2023/5 | 1.46 | -17.08 | 53.23 | 9.0 | 35.41 | 4.8 | N/A | 疫情趨緩及RBK挹注所致 | ||
| 2023/4 | 1.76 | 10.94 | 59.89 | 7.55 | 32.43 | 4.8 | N/A | 疫情趨緩及RBK挹注所致 | ||
| 2023/3 | 1.58 | 8.51 | 22.55 | 5.79 | 25.86 | 5.79 | N/A | - | ||
| 2023/2 | 1.46 | -46.74 | 5.69 | 4.2 | 27.16 | 7.22 | N/A | - | ||
| 2023/1 | 2.74 | -9.16 | 42.59 | 2.74 | 42.59 | 7.58 | N/A | - | ||
| 2022/12 | 3.02 | 65.52 | 95.1 | 19.39 | 27.14 | 6.53 | N/A | 新品牌RBK挹注,大型團購訂單 | ||
| 2022/11 | 1.82 | 8.36 | -4.4 | 16.37 | 19.47 | 4.97 | N/A | - | ||
| 2022/10 | 1.68 | 15.01 | 2.46 | 14.55 | 23.33 | 5.04 | N/A | - | ||
| 2022/9 | 1.46 | -22.81 | 44.66 | 12.86 | 26.71 | 5.05 | N/A | - | ||
| 2022/8 | 1.9 | 12.11 | 50.49 | 11.4 | 24.73 | 4.75 | N/A | 疫情趨緩及新品牌挹注效益所致 | ||
| 2022/7 | 1.69 | 45.19 | 107.83 | 9.5 | 20.61 | 3.81 | N/A | 去年受三級警戒疫情影響所致 | ||
| 2022/6 | 1.16 | 22.41 | 279.3 | 7.81 | 10.56 | 3.22 | N/A | 去年受三級警戒疫情影響所致 | ||
| 2022/5 | 0.95 | -13.48 | -1.21 | 6.65 | -1.63 | 3.34 | N/A | - | ||
| 2022/4 | 1.1 | -14.95 | -9.84 | 5.7 | -1.7 | 3.77 | N/A | - | ||
| 2022/3 | 1.29 | -6.41 | 21.37 | 4.6 | 0.46 | 4.6 | N/A | - | ||
| 2022/2 | 1.38 | -28.15 | -21.85 | 3.3 | -5.88 | 4.85 | N/A | - | ||
| 2022/1 | 1.92 | 24.27 | 10.32 | 1.92 | 10.32 | 5.38 | N/A | - | ||
| 2021/12 | 1.55 | -18.89 | -32.12 | 15.25 | -14.5 | 5.1 | N/A | - | ||
| 2021/11 | 1.91 | 16.15 | 9.54 | 13.7 | -11.92 | 4.56 | N/A | - | ||
| 2021/10 | 1.64 | 62.38 | -23.38 | 11.79 | -14.63 | 3.91 | N/A | - | ||
| 2021/9 | 1.01 | -19.7 | -6.21 | 10.15 | -13.02 | 3.08 | N/A | - | ||
| 2021/8 | 1.26 | 54.83 | -3.35 | 9.14 | -13.72 | 2.38 | N/A | - | ||
| 2021/7 | 0.81 | 164.98 | -35.42 | 7.88 | -15.17 | 2.08 | N/A | - | ||
| 2021/6 | 0.31 | -68.11 | -72.3 | 7.07 | -11.99 | 0.0 | N/A | 本月營收較去年同期衰退,係受疫情影響所致。 | ||
| 2021/5 | 0.96 | -21.04 | -26.38 | 6.76 | -2.34 | 0.0 | N/A | - |